CHEMICAL-SYNTHETIC SERVICES in Europe
R&D and GMP manufacturing site, Bowburn, Durham, UK
About the plant
As an independent, chemistry-led research, development, and manufacturing partner, we combine rigorous execution and hands-on experience with the agility and care that bigger players can’t match. You deal directly with highly skilled chemists and senior decision-makers who adapt to your needs, respond quickly, and think beyond the brief. Whether you´re scaling a complex molecule for clinic readiness or navigating the unique challenges of diagnostics and materials, we bring cross-sector insight, strategic foresight, and a values-driven approach to every project.
Trusted by long-standing partners and built for whatever’s next, we´re here to flex, scale, and support your every ambition; with confidence, clarity, and chemistry that connects.
Certifications
- ISO
- MHRA (UK GMP)
Activity
- CHEMICAL-SYNTHETIC, SERVICES, RSM (Raw Starting Materials), Intermediates, Fine Chemicals, API (Active Pharmaceutical Ingredients), Excipients, Building Blocks manufacturing
Features
- Uses: Investigational, Preclinical, Phase I, Phase II, Human, Veterinary
- Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
- DEA: Schedule I (high potential for abuse / no medical use)
- BSL: N/A
- Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and blood forming organs, (C) Cardiovascular system, (D) Dermatologicals, (G) Genito urinary system and sex hormones, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V04) Diagnostic agents
- Markets: N/A
Batch Size / Reactor
- Small, Medium, 1 - 10 L, 10-100 L
Services
- Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Preformulation studies, R&D, Process development, Process optimization, Process validation, Stability studies design, Stability studies execution, ICH Stability studies, Tech transfer, Research batches, Scale-up, Pilot batches, Batch records, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, Batch certification / release, GMP documentation, Salt screening, Co-crystal screening, Polymorph screening, Crystallization screening, Chiral resolution screening, Solid form selection, Nitrosamine risk assessment, Customized block synthesis, Impurity synthesis
